Spyre Therapeutics, Inc. (SYRE) Earnings Per Share (EPS)
Spyre Therapeutics, Inc. (SYRE) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$61.25 |
| 2020-12-31 | -$38.00 |
| 2021-12-31 | -$25.00 |
| 2022-12-31 | -$24.75 |
| 2023-12-31 | -$49.12 |
| 2024-12-31 | N/A |
| 2025-12-31 | -$1.98 |
How SYRE compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| HBIO | Harvard Bioscience Inc. | -$1.28 |
| NTRA | Natera Inc. | -$1.52 |
| FLGT | Fulgent Genetics Inc. | -$1.97 |
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
| IONS | Ionis Pharmaceuticals Inc. | -$2.38 |
These are five companies in the same sector as SYRE with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Spyre Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SYRE")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SYRE | $101.85 | -2.15% | 0.53M |
| 3 | ||||
| 4 | ||||
| 5 |